Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Massarotti

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of the American Heart Association|June 16, 2021
Coronary Microvascular Dysfunction in Systemic Lupus ErythematosusBrittany N Weber, Emma Stevens, Leanne Barrett, et al.
Arthritis and Rheumatism|May 29, 2007
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohortsHye-Soon Lee, Patricia Irigoyen, Marlena Kern, et al.
Arthritis and Rheumatism|December 2, 2005
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope allelesPatricia Irigoyen, Annette T Lee, Mark H Wener, et al.
Contemporary Clinical Trials|July 16, 2025
Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and "decentralized" clinical recruitment designGregory C McDermott, Mary Jeffway, Thany Seyok, et al.
JACC. Cardiovascular Imaging|March 21, 2021
Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory DisordersBrittany N Weber, Emma Stevens, Lourdes M Perez-Chada, et al.
Lupus Science & Medicine|November 15, 2014
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurementsChaim Putterman, Richard Furie, Rosalind Ramsey-Goldman, et al.
Lupus Science & Medicine|May 7, 2020
Cell-bound complement activation products associate with lupus severity in SLECristina Arriens, Roberta Vezza Alexander, Sonali Narain, et al.
The Journal of Rheumatology|December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification CriteriaSindhu R Johnson, Dinesh Khanna, David Daikh, et al.
Journal of the American Heart Association|April 30, 2024
Interplay Between Systemic Inflammation, Myocardial Injury, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis: Results From the LiiRA StudyBrittany Weber, Dana Weisenfeld, Elena Massarotti, et al.
Arthritis Care & Research|April 15, 2010
Development and initial validation of a self-assessed lupus organ damage instrumentKaren H Costenbader, Munther Khamashta, Silvia Ruiz-Garcia, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of the American Heart Association|June 16, 2021
Coronary Microvascular Dysfunction in Systemic Lupus ErythematosusBrittany N Weber, Emma Stevens, Leanne Barrett, et al.
Arthritis and Rheumatism|May 29, 2007
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohortsHye-Soon Lee, Patricia Irigoyen, Marlena Kern, et al.
Arthritis and Rheumatism|December 2, 2005
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope allelesPatricia Irigoyen, Annette T Lee, Mark H Wener, et al.
Contemporary Clinical Trials|July 16, 2025
Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and "decentralized" clinical recruitment designGregory C McDermott, Mary Jeffway, Thany Seyok, et al.
JACC. Cardiovascular Imaging|March 21, 2021
Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory DisordersBrittany N Weber, Emma Stevens, Lourdes M Perez-Chada, et al.
Lupus Science & Medicine|November 15, 2014
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurementsChaim Putterman, Richard Furie, Rosalind Ramsey-Goldman, et al.
Lupus Science & Medicine|May 7, 2020
Cell-bound complement activation products associate with lupus severity in SLECristina Arriens, Roberta Vezza Alexander, Sonali Narain, et al.
The Journal of Rheumatology|December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification CriteriaSindhu R Johnson, Dinesh Khanna, David Daikh, et al.
Journal of the American Heart Association|April 30, 2024
Interplay Between Systemic Inflammation, Myocardial Injury, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis: Results From the LiiRA StudyBrittany Weber, Dana Weisenfeld, Elena Massarotti, et al.
Arthritis Care & Research|April 15, 2010
Development and initial validation of a self-assessed lupus organ damage instrumentKaren H Costenbader, Munther Khamashta, Silvia Ruiz-Garcia, et al.
Pageof 4